Table 3 Factors associated with high MICA expression in the cancer.
High MICA (n = 99) | Low MICA (n = 94) | P value | OR | C.I. | P value | |
|---|---|---|---|---|---|---|
Age (years, mean ± SD) | 63.2 ± 12.1 | 62.3 ± 10.9 | 0.61 | |||
Male gender, n (%) | 79 (79.8) | 65 (69.1) | 0.09 | |||
BMI (kg/m2, mean ± SD) | 24.6 ± 3.2 | 25.1 ± 5.3 | 0.41 | |||
AST (IU/L, mean ± SD) | 56 ± 36 | 55 ± 40 | 0.92 | |||
ALT (IU/L, mean ± SD) | 48 ± 34 | 54 ± 45 | 0.29 | |||
α-fetoprotein >20 ng/mL, n (%) | 42 (42.4) | 41 (43.6) | 0.71 | |||
Fibrosis stage 3–4, n (%) | 54 (54.5) | 50 (53.2) | 0.85 | |||
HBV/HCV, n | 44/20 | 43/31 | 0.20 | |||
Child-Pugh score A, n (%) | 81 (81.8) | 82 (91.1) | 0.63 | |||
MICA rs2596542 A allele, n (%)* | 26 (27.1) | 64 (70.3) | <0.001 | 0.16 | 0.08–0.30 | <0.001 |
BCLC stage 0-A, n (%) | 59 (59.6) | 58 (61.7) | 0.82 | |||
TMN stage 1–2, n (%) | 21 (21.2) | 13 (13.8) | 0.18 | |||
Tumor size >5 cm, n (%) | 34 (34.3) | 36 (38.3) | 0.57 | |||
Tumor number >2, n (%) | 19 (19.2) | 13 (13.8) | 0.32 | |||
Poor differentiated HCC† | 27 (42.9) | 21 (37.5) | 0.55 |